| abstract |
The present invention provides compounds of formula (I) and especially 2-[bis(4-fluorophenyl)methyl]-2,7-diazaspiro[ 4.5] Decane‑10‑one derivatives and related compounds for the treatment of sexual dysfunction, affective disorders, anxiety, depression, chronic fatigue, hyperactive Tourette syndrome, Angelman syndrome, attention deficit disorder (ADD) , attention-deficit hyperactivity disorder (ADHD), obesity, pain, obsessive-compulsive disorder, movement disorder, CNS disorder, sleep disorder, narcolepsy, conduct disorder, substance abuse (including smoking cessation), eating disorder, and impulse control disorder . |